NMIC Bulletin Vol.30 No. 2 Prostate Cancer Survivorship And Androgen Deprivation Therapy
Share
Print
13 May, 2024
Specialist-initiated androgen deprivation therapy (ADT/hormonal therapy is the mainstay of prostate cancer treatment and is often continued for long periods of time, with prescribing ongoing in primary care
In Addition to adverse drug effects such as hot flushes, fatigue and sexual issues, hormonal therapy can also affect a patient's cardiometabolic, bone and mental health
Pharmacological and non-pharmacological treatments can alleviate the burden of adverse effects associated with hormonal therapy, increase adherence and reduce distress for patients
Prescribers should be aware that there are many potential drug-drug interactions and some important specialist-led monitoring requirements associated with hormonal therapy